« Non substituable » : une thèse de médecine générale énonce la réalité des chiffres
25/05/2014New Telemedicine Literature Review Released
26/05/2014Cost of New Drug Complicates Access for Inmates and the Poor cc @giomarsi
See on Scoop.it – 4- PATIENT EMPOWERMENT & E-PATIENT by PHARMAGEEK
Sovaldi is considered a breakthrough for treating hepatitis C. But at about $1,000 a pill, it is raising questions about how available it will be to those who receive government-subsidized health care.
See on www.nytimes.com
